GSK: Protocol Summaries: Compounds

Quick Search

By Phase:

By Study Type:

By Population:

By Post Marketing Commitment:

By Status:

By Country:

GSK Study ID	Phase	Title	Status
AC6108697	Phase 1	A randomized double-blind, placebo-controlled, crossover, dose escalation study to examine the safety, tolerability, pharmacodynamics and pharmacokinetics of single inhaled doses of GSK704838 and tiotropium bromide	Completed